Association of normalized protein catabolic rate (nPCR) with the risk of bone fracture in patients undergoing maintenance hemodialysis: The Q-Cohort Study

被引:7
|
作者
Ohnaka, Shotaro [1 ]
Yamada, Shunsuke [2 ]
Tsujikawa, Hiroaki [2 ]
Arase, Hokuto [2 ]
Taniguchi, Masatomo [3 ]
Tokumoto, Masanori [4 ]
Tsuruya, Kazuhiko [5 ]
Nakano, Toshiaki [2 ]
Kitazono, Takanari [2 ]
机构
[1] Tagawa Municipal Hosp, Div Nephrol, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[3] Fukuoka Renal Clin, Fukuoka, Japan
[4] Fukuoka Dent Coll, Dept Internal Med, Fukuoka, Japan
[5] Nara Med Univ, Dept Nephrol, Nara, Japan
关键词
Bone fracture; Hemodialysis; Normalized protein catabolic rate; Protein intake; DIALYSIS THERAPY; INDOXYL SULFATE; HIP; SURVIVAL; HEALTH;
D O I
10.1016/j.clnu.2020.07.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Normalized protein catabolic rate (nPCR) is used as a surrogate for daily dietary protein intake and nutritional status in patients receiving maintenance hemodialysis. It remains uncertain whether the nPCR level is associated with the incidence of bone fracture. Methods: A total of 2869 hemodialysis patients registered in the Q-Cohort Study, a multicenter, prospective, observational study, were followed up for 4 years. The primary outcome was bone fracture at any site. The main exposure was the nPCR level at baseline. Patients were assigned to four groups based on their baseline nPCR levels (G1: <0.85, G2: 0.85<, <0.95, G3: 0.95<, <1.05 [reference], G4: >1.05 g/kg/ day). We examined the relationship between the nPCR levels and the risk for bone fracture using Cox proportional hazards models. Results: During the follow-up period, 136 patients experienced bone fracture at any site. In the multi variable analyses, the risk for bone fracture was significantly higher in the lowest (G1) and highest (G4) nPCR groups than the reference (G3) group (hazard ratio [95% confidence intervals]: G1, 1.93 [1.04-3.58]; G2, 1.27 [0.67-2.40]; G3 1.00 (reference); G4, 2.21 [1.25-3.92]). The association remained almost unchanged, even when patients were divided into sex-specific nPCR quartiles, when analysis was limited to patients with a dialysis vintage >2 years, assumed to have lost residual kidney function, or when a competing risk model was applied. Conclusions: Our results suggest that both lower and higher nPCR levels are associated with an increased risk for bone fracture in hemodialysis patients. 0 2020 Published by Elsevier Ltd.
引用
收藏
页码:997 / 1004
页数:8
相关论文
共 50 条
  • [21] INFLUENCE OF POLYSULFONE MEMBRANE POROSITY ON NORMALIZED PROTEIN CATABOLIC RATES (NPCR) IN CHRONIC-HEMODIALYSIS PATIENTS
    SAKAI, K
    ELLIS, P
    MAGNUSSON, MO
    PAGANINI, EP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 503 - 503
  • [22] Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study
    Sho Shimamoto
    Shunsuke Yamada
    Hiroto Hiyamuta
    Hokuto Arase
    Masatomo Taniguchi
    Kazuhiko Tsuruya
    Toshiaki Nakano
    Takanari Kitazono
    Clinical and Experimental Nephrology, 2022, 26 : 59 - 67
  • [23] Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study
    Shimamoto, Sho
    Yamada, Shunsuke
    Hiyamuta, Hiroto
    Arase, Hokuto
    Taniguchi, Masatomo
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (01) : 59 - 67
  • [24] Malnutrition-Inflammation Complex Syndrome and Bone Fractures and Cardiovascular Disease Events in Patients Undergoing Hemodialysis: The Q-Cohort Study
    Yamada, Shunsuke
    Arase, Hokuto
    Yoshida, Hisako
    Kitamura, Hiromasa
    Tokumoto, Masanori
    Taniguchi, Masatomo
    Hirakata, Hideki
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    KIDNEY MEDICINE, 2022, 4 (03)
  • [25] Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-Cohort Study
    Hiyamuta, Hiroto
    Yamada, Shunsuke
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2021, 316 : 25 - 31
  • [26] Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study
    Arase, Hokuto
    Yamada, Shunsuke
    Yotsueda, Ryusuke
    Taniguchi, Masatomo
    Yoshida, Hisako
    Tokumoto, Masanori
    Nakano, Toshiaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2018, 275 : 115 - 123
  • [27] IMPACT OF CARDIOTHORACIC RATIO FOR MORTALITY IN PATIENTS ON HEMODIALYSIS: THE Q-COHORT STUDY
    Yotsueda, R.
    Tanaka, S.
    Eriguchi, M.
    Taniguchi, M.
    Hirakata, H.
    Tsuruya, K.
    Kitazono, T.
    NEPHROLOGY, 2016, 21 : 190 - 190
  • [28] Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study
    Tsuneyoshi, Shoji
    Matsukuma, Yuta
    Kawai, Yasuhiro
    Hiyamuta, Hiroto
    Yamada, Shunsuke
    Kitamura, Hiromasa
    Tanaka, Shigeru
    Taniguchi, Masatomo
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2021, 323 : 30 - 36
  • [29] Association between Serum C-Reactive Protein Concentrations and Risk of Cancer-Related Mortality in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study
    Uchida, Yushi
    Nakano, Toshiaki
    Hiyamuta, Hiroto
    Kitamura, Hiromasa
    Taniguchi, Masatomo
    Ooboshi, Hiroaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    BLOOD PURIFICATION, 2023, 52 (7-8) : 694 - 701
  • [30] Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study
    Kitamura, Hiromasa
    Yamada, Shunsuke
    Hiyamuta, Hiroto
    Yotsueda, Ryusuke
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (06) : 923 - 936